Fact CheckerSign in

NCT06522737RecruitingPhase 3

A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

A Multicentre, Open-label, Phase 3, Randomised Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype

Source: ClinicalTrials.gov · Last updated 6 Apr 2026

Brief summary (registry, in English)

The study will evaluate the progression-free survival benefit of duvelisib monotherapy as compared to investigator's choice of gemcitabine or bendamustine in participants with relapsed/refractory nodal T cell lymphoma with TFH phenotype.

Status (registry)
Recruiting
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
124 (estimated)
First submitted
22 Jul 2024
Start date
19 May 2025
Primary completion date
Feb 2028
Lead sponsor
SecuraBio
NCT number
NCT06522737
EU CT number
2024-516605-23-00

What you commit to

  • Study type: Interventional · Phase 3
  • Planned participants: 124
  • From 19 May 2025 to the primary completion date, Feb 2028
  • 47 sites in 10 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Received prior allogeneic transplant any time in the past or received autologous transplant within 60 days prior to the first dose of study drug.
  • Received prior treatment with a phosphoinositide-3-kinase (PI3K) inhibitor.
  • Prior exposure to planned study treatment investigator's choice therapy (gemcitabine or bendamustine) within 60 days prior to the first dose of study drug.
    • Other protocol-defined criteria apply.

Other illness

  • Cutaneous-only disease.

Who the study is looking for

  • Pathologically confirmed nodal T cell lymphoma with TFH phenotype according to the criteria of the World Health Organization classification (Swerdlow 2017, Alaggio 2022) including any one of Angioimmunoblastic T cell lymphoma (AITL), follicular T cell lymphoma, and other nodal peripheral T cell lymphoma (PTCL) with a TFH phenotype.
  • Relapsed or refractory to at least 1 prior systemic, cytotoxic therapy for T cell lymphoma.
  • Measurable disease as defined by Lugano 2014 criteria (Cheson 2014) for T cell lymphoma.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (47)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universitair Ziekenhuis Gent
Coordinator of this site? Confirm its status
GentBelgiumRecruiting
UZ Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumRecruiting
Vseobecna fakultni nemocnice v Praze
Coordinator of this site? Confirm its status
PragueCzechiaRecruiting
KLINIKEN ESSEN SUED Evangelisches Krankenhaus Essen-Werden gGmbH
Coordinator of this site? Confirm its status
EssenGermanyRecruiting
Universitaetsmedizin Goettingen
Coordinator of this site? Confirm its status
GoettingenGermanyRecruiting
Martin-Luther-Universitaet Halle-Wittenberg
Coordinator of this site? Confirm its status
Halle (Saale)GermanyRecruiting
Universitaet Leipzig
Coordinator of this site? Confirm its status
LeipzigGermanyRecruiting
Rotkreuzklinikum Muenchen gGmbH
Coordinator of this site? Confirm its status
MunichGermanyRecruiting
Region Midtjylland
Coordinator of this site? Confirm its status
Aarhus NDenmarkRecruiting
Rigshospitalet
Coordinator of this site? Confirm its status
Copenhagen OeDenmarkRecruiting
Odense University Hospital
Coordinator of this site? Confirm its status
Odense CDenmarkRecruiting
Institut Catala D'oncologia
Coordinator of this site? Confirm its status
L'Hospitalet de LlobregatSpainRecruiting
Hospital Universitario Fundación Jiménez Díaz
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital Universitario De Salamanca
Coordinator of this site? Confirm its status
SalamancaSpainRecruiting
University Hospital Virgen Del Rocio S.L.
Coordinator of this site? Confirm its status
SevillaSpainRecruiting
Centre Hospitalier Universitaire De Caen Normandie
Coordinator of this site? Confirm its status
Caen Cedex 9FranceRecruiting
University Hospital Of Clermont-Ferrand
Coordinator of this site? Confirm its status
Clermont-FerrandFranceRecruiting
Institut Paoli-Calmettes
Coordinator of this site? Confirm its status
MarseilleFranceRecruiting
Centre Hospitalier Universitaire De Montpellier
Coordinator of this site? Confirm its status
Montpellier Cedex 5FranceRecruiting
Centre Hospitalier Universitaire de Nantes
Coordinator of this site? Confirm its status
NantesFranceRecruiting
Assistance Publique Hopitaux de Paris
Coordinator of this site? Confirm its status
ParisFranceRecruiting
Centre Hospitalier Universitaire de Bordeaux
Coordinator of this site? Confirm its status
PessacFranceRecruiting
Hospices Civils de Lyon
Coordinator of this site? Confirm its status
Pierre-BéniteFranceRecruiting
Centre Hospitalier Universitaire De Rennes
Coordinator of this site? Confirm its status
Rennes Cedex 9FranceRecruiting
Centre Henri Becquerel
Coordinator of this site? Confirm its status
Rouen CedexFranceRecruiting
Institut Curie
Coordinator of this site? Confirm its status
Saint-CloudFranceRecruiting
Institut Gustave Roussy
Coordinator of this site? Confirm its status
VillejuifFranceRecruiting
Beatson West of Scotland Cancer Centre
Coordinator of this site? Confirm its status
GlasgowUnited KingdomRecruiting
University Hospitals of Leicester NHS Trust
Coordinator of this site? Confirm its status
LeicesterUnited KingdomRecruiting
UCLH NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
The Christie NHS Foundation Trust
Coordinator of this site? Confirm its status
ManchesterUnited KingdomRecruiting
Nottingham University Hospitals NHS Trust
Coordinator of this site? Confirm its status
NottinghamUnited KingdomRecruiting
Oxford University Hospitals NHS Foundation Trust
Coordinator of this site? Confirm its status
OxfordUnited KingdomRecruiting
The Royal Marsden NHS Foundation Trust
Coordinator of this site? Confirm its status
SuttonUnited KingdomRecruiting
Azienda Ospedaliero-Universitaria Ss.Antonio E Biagio E C.Arrigo Alessandria
Coordinator of this site? Confirm its status
AlexandriaItalyRecruiting
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII
Coordinator of this site? Confirm its status
BergamoItalyRecruiting
Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico
Coordinator of this site? Confirm its status
BolognaItalyRecruiting
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Coordinator of this site? Confirm its status
NaplesItalyRecruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Coordinator of this site? Confirm its status
RomeItalyRecruiting
Amsterdam UMC Stichting
Coordinator of this site? Confirm its status
AmsterdamNetherlandsRecruiting
Leids Universitair Medisch Centrum (LUMC)
Coordinator of this site? Confirm its status
LeidenNetherlandsRecruiting
Academisch Ziekenhuis Maastricht
Coordinator of this site? Confirm its status
MaastrichtNetherlandsRecruiting
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Coordinator of this site? Confirm its status
RotterdamNetherlandsRecruiting
Pratia S.A.
Coordinator of this site? Confirm its status
CracowPolandRecruiting
Uniwersyteckie Centrum Kliniczne
Coordinator of this site? Confirm its status
GdanskPolandRecruiting
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
Coordinator of this site? Confirm its status
WarsawPolandRecruiting
Instytut Hematologii I Transfuzjologii
Coordinator of this site? Confirm its status
WarsawPolandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.